Mahathir Bayena

Labcorp (NYSE:LH) announced its second-quarter 2026 financial results, posting a 5.8% revenue increase to $3.73 billion driven by strong diagnostic testing volume.

Regeneron Pharmaceuticals (NASDAQ:REGN) reported second-quarter 2026 total revenue of $4.29 billion, up 17% year over year, supported by higher collaboration revenue and product sales growth.

Omnicell (NASDAQ:OMCL) reported second-quarter 2026 revenue of $312 million, up 7% year over year, driven by growth in connected devices, SaaS, Expert Services and technical services.

Darling Ingredients (NYSE:DAR) announced its second-quarter 2026 financial results, highlighted by an increase in total net sales to $1.7 billion.

Escalade (NASDAQ:ESCA) announced its second-quarter 2026 financial results, highlighted by a 6.2% year-over-year increase in net sales to $57.7 million.

Lockheed Martin (NYSE:LMT) received a seven-year undefinitized contract action modification from the U.S. government worth up to $53.9 billion to produce PAC-3 Missile Segment Enhancement (MSE) interceptors.

The Magnum Ice Cream Company (NYSE:MICC) reported first-half 2026 revenue of €4.7 billion, up from €4.5 billion a year earlier, driven by 4.7% organic sales growth across all regions.

Canadian digital asset manager 3iQ has signed a strategic partnership with Gelephu Mindfulness City (GMC) to help develop the Bhutanese economic zone's digital asset ecosystem.

Paradigm Biopharmaceuticals (ASX:PAR) completed patient enrolment in its global Phase 3 study of Zilosul for knee osteoarthritis pain.

EBR Systems (ASX:EBR) reported 46 commercial implants for Q2 2026 and preliminary revenue of US$2.6M to US$3M.